排序方式: 共有17条查询结果,搜索用时 15 毫秒
1.
Clinical Evaluation of a New Single Pass Lead VDD Pacing System 总被引:3,自引:0,他引:3
ILYA E. OVSYSHCHER AMOS KATZ CHAVA BONDY 《Pacing and clinical electrophysiology : PACE》1994,17(11):1859-1864
Twenty-five patients with second- to third-degree AV block and normal sinus function (16 males, mean age 60 ± 18; range 15–78 years) underwent implantation of WD pacemakers (THERA VDD, Medtronic, Inc.) with a single pass (SP) lead. Results: During implantation the mean amplitude of the atrial (A) signal was 3.9 ±1.4 mV (range 2.0–7.8 mV). Stable, acceptable A-signals during implantation were usually observed in the mid- or lower part of the right atrium. The lead tip electrical parameters were not compro mised in any patient in order to obtain an acceptable A-signal. To verify VDD device function, patients underwent pacing system analysis on the second day and again 1, 3, and 6 months after implantation. Acute and chronic electrical measurements in the ventricle were similar to those with regular steroid leads. During follow-up tests, stable atrial sensing (A ≥ 0.7mV) was found in all but one patient (in whom A was 0.25–0.5 mV and an intermittent loss of atriai sensing occurred). There was no difference between serial measurements of A-signal amplitudes on the second day or 1, 3, and 6 months after implantation: 1.9 ± 1.3 mV, 1.5 ± 0.6 mV, 1.3 ± 0.8 mV, and 1.5 ± 1.1 mV, respectively. The mean implantation time was 54.0 ± 17 minutes and the mean fluoroscopy time was 3.2 ±1.3 minutes. Conclusions: SP lead VDD pacing is reliable and easy to manage with dependable atriai sensing and ventricular pacing. The significant reduction in atriai postimplantation amplitude is related to the different techniques used for measuring acute and chronic atriai signals. 相似文献
2.
Impedance Cardiography for Cardiac Output Estimation in Pacemaker Patients: Review of the Literature 总被引:2,自引:0,他引:2
Impedance curdiogrciphy permits noninvasive beat-to-beat determination of cardiac output, the product of the amplitude of the first derivative of thonicic impedance signal (dZ/dt), the venfricular ejection time, and heart rate corrected by the distance between the measuring electrodes. Its use is based on: (1) the dZ/dt signal that originates from the upper thorax; (2) the ventricular ejection period measured by the dZ/dt curve that occurs between the opening and closing of the aortic vnlve: (3) the dZ/dt curve is similar in morphology and timing to the aortic flow curve measured by an electromagnetic flowmefer with a significant linear correlation (r = 0.9) between dZ/dt and peak aortic flow; (4) similarity of the linear correlation between stroke volume, determined by the flowmeter and the impedance signal; and (5) significant reduction of the dZ/dt signal by 90% follows simultaneous occlusion of the aorta and the pulmonary artery. The rapid systolic portion of the impedance signal occurs only when blood is ejected into the aorta and is independent of right ventricular ejection. Most studies comparing impedance cardiography results with standard cardiac output determination have shown a correlation of 0.7–0.9. While the accuracy of impedance cardiography remains controversial and can be affected by the inherent limitations of the technique and by low cardiac output, intracardiac shunts. and valvular regurgitation. the high reproducibility of the method is established and may be comparable or superior to other commonly used techniques. When accurate determination of cardiac output is crucial, impedance cardiography may be used in conjunction with a standard technique to establish a baseline reference, thereby permitting further analysis. If only the trend need be followed, the high reproducibility of impedance cardiography measurements allows small changes in cardiac output to be detected on a frequent and ongoing basis. The ease and precision of this technique warrants its more widespread use in the assessment of pacemaker patients. Further use of this promising technique will allow a better definition of its role in the assessment of a wide range of cardiac patients. 相似文献
3.
4.
ILYA OVSYSHCHER JAY N. GROSS STEPHEN BLUMBERG SEYMOUR FURMAN 《Pacing and clinical electrophysiology : PACE》1992,15(11):1932-1936
Responses to orthostasis may be altered in states associated with autonomic dysfunction. Computerized impedance cardiography, a noninvasive method for continuous assessment of stroke volume and mean blood pressure, was utilized to study the postural hemodynamic changes in eight normal and 27 patients with DDD pacemakers. Twenty patients with complete heart block (five with heart failure) were studied in the VDD mode and seven patients with sick sinus syndrome were assessed in DVI (four] or VDD (three). The results with pacemaker patients are significantly different from those observed in normal. Pacemaker patient responses to standing included: (1) a reduction in systolic, diastolic, and mean blood pressure; (2) an increase in heart rate in patients with intact sinus node function and no change in patients with sick sinus syndrome; and (3) stroke volume was unchanged in patients with sick sinus syndrome or heart failure and only modest reduction occurred in the remaining patients. Conclusions: (1) No reduction in stroke volume during upright posture occurs in DDD patients with sick sinus syndrome and this appears to be a compensatory reaction to an inadequate heart rate response to standing; (2) The hemodynamic response of DDD patients to the assumption of an upright posture is consistent with autonomic dysfunction; and (3) The primary cause for autonomic dysfunction in DDD patients may be the asynchronous ventricular depolarization caused by right ventricular pacing. 相似文献
5.
Single Lead VDD Pacing: Multicenter Study 总被引:2,自引:0,他引:2
ILYA E. OVSYSHCHER AMOS KATZ SHIMON ROSENHECK SHIMSHON ERDMAN CHAVA BONDY 《Pacing and clinical electrophysiology : PACE》1996,19(11):1768-1771
Optimal treatment for patients with AV block and normal sinoatrial node (SA) function entails atrial sensing and ventricular pacing (VDD mode). Single-lead VDD pacing preserves AV synchrony, precludes the need to insert two leads, and makes the implanter's work simpler and quicker. Our objectives were to verify the performance of the Thera(tm) VDD pacing system (Medtronic, Inc., Minneapolis, MN, USA), and evaluate the effectiveness of its atrial sensing and its ventricular sensing and pacing. In 165 patients, 150 adults (mean age 62 ± 18 years) and 15 children (mean age 7 ± 5 years) with 1°–3° AV block and normal SA node function, a Thera VDD system (Models 8948 or 8968) was implanted. Intraoperative ventricular electrical measurements were not significantly different from those of VVI pacemakers. The mean amplitude of the atrial signal during implantation was 4.1 ± 1.9 mV. Optimal atrial signals during implantation were usually obtained in the mid or lower part of the right atrium by using a special technique. Adequate atrial measurements remained stable throughout 24 months. There was no difference between serial measurements of atrial signal amplitudes at predischarge and during follow-up visits. Reposition of the lead was done in 2 patients (1.4%), and reprogramming to VVI in 7 patients: due to atrial fibrillation in 3 (1.8%) and due to atrial undersensing in 4 patients (2.4%). Thera VDD pacing is reliable and easy to manage with dependable atrial sensing and ventricular pacing. The survival rate of VDD pacing at 2 years was 96%. 相似文献
6.
7.
BOAZ ROSEN ILIYA A. OVSYSHCHER REUVEN ZIMLICHMAN 《Pacing and clinical electrophysiology : PACE》1988,11(11):1555-1558
We present two patients who developed complete heart block due to treatment with methyldopa. After discontinuing methyldopa, conduction disturbances completely disappeared and recurred upon rechallenge with the medication. It is assumed that methyldopa can impair the myocardial conduction system by its central sympatholytic effect. Conduction anomalies should be excluded prior to treatment with methyldopa, and during treatment with the medication, the patients should be routinely screened for the presence of conduction anomalies. 相似文献
8.
ILYA OVSYSHCHER VICTOR GUETTA CHAVA BONDY AVI PORATH 《Pacing and clinical electrophysiology : PACE》1992,15(2):211-218
Ten patients underwent implantation of a rate adaptive ventricular pacing system with a new pulse generator and lead. The unipolar lead has a steroid eluting tip and a pressure sensor. The first derivative of the signal from this sensor, dP/dt, is determined and the pacemaker rate is varied in response to changes in the right ventricular dP/dtMAX. During implantation, dP/dt values were in the range of 180-720 mm Hg/sec. The autothreshold for pacing at 2.5 V remained unchanged 1 month after implantation (0.065 +/- 0.045 msec, range 0.05-2.00 msec) and only slightly increased after 3 months (0.075 +/- 0.045 msec, range 0.05-2.00 msec). A significant correlation existed between the dP/dt measured during implantation and the right ventricular pressure measured by telemetry at follow-up visits (r = 0.93, P = 0.0001). Initial pacemaker programming was performed on the second day after implantation following a short walk and was adjusted subsequent to follow-up visits according to the patient's subjective assessment and in accordance with the results of exercise tests and Holter monitoring. Exercise and Holter tests did not significantly change initial programming. There was a significant correlation between right ventricular systolic pressure and the rate response setting (r = -0.66, P less than 0.05). During dP/dt pacing, all patients felt well, and eight of these reported an improvement compared to nonrate adaptive pacing. The heart rate response to effort and recovery was appropriate. It was concluded that: (1) right ventricular dP/dt is a suitable parameter for controlling the pacing rate; (2) appropriate programming of the dP/dt pacemaker results in a suitable heart rate response to exercise and recovery. 相似文献
9.
10.
ABSTRACT. Kovar, I. and Mayne, P. (Departments of Child Health and Chemical Pathology, Westminster Medical School and Hospital, London, England). Plasma alkaline phosphatase activity in the preterm neonate. Acta Paediatr Scand, 70:501,.–Rickets was diagnosed clinically and confirmed radiologically in a preterm infant at 12 weeks of age, who despite therapy with vitamin D died. Four preterm infants who were subsequently admitted to the nursery had their biochemistry followed serially as controls. All infants demonstrated a marked increase and then subsequent decrease in plasma alkaline phosphatase activity; the peak value occurring near to what should have been gestationally term. The plasma alkaline phosphatase was of bony origin. Rickets was confirmed radiologically in only one of these four infants. Rising and markedly elevated plasma alkaline phosphatase activity appears to be common in this group of infants and may represent a physiological increase in osteoblastic activity and increasing bone mineralisation in what would have been the infants' 3rd trimester of pregnancy and immediate newborn period. 相似文献